Cargando…

Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity

Amyotrophic lateral sclerosis (ALS) is a severe adult motor neuron disease that causes progressive neuromuscular atrophy, muscle wasting, weakness, and depressive-like symptoms. Our previous research suggests that mercury levels are directly associated with ALS progression. MeHg+-induced ALS is char...

Descripción completa

Detalles Bibliográficos
Autores principales: Shandilya, Ambika, Mehan, Sidharth, Kumar, Sumit, Sethi, Pranshul, Narula, Acharan S., Alshammari, Abdulrahman, Alharbi, Metab, Alasmari, Abdullah F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228431/
https://www.ncbi.nlm.nih.gov/pubmed/35745001
http://dx.doi.org/10.3390/molecules27123878
_version_ 1784734469095161856
author Shandilya, Ambika
Mehan, Sidharth
Kumar, Sumit
Sethi, Pranshul
Narula, Acharan S.
Alshammari, Abdulrahman
Alharbi, Metab
Alasmari, Abdullah F.
author_facet Shandilya, Ambika
Mehan, Sidharth
Kumar, Sumit
Sethi, Pranshul
Narula, Acharan S.
Alshammari, Abdulrahman
Alharbi, Metab
Alasmari, Abdullah F.
author_sort Shandilya, Ambika
collection PubMed
description Amyotrophic lateral sclerosis (ALS) is a severe adult motor neuron disease that causes progressive neuromuscular atrophy, muscle wasting, weakness, and depressive-like symptoms. Our previous research suggests that mercury levels are directly associated with ALS progression. MeHg+-induced ALS is characterised by oligodendrocyte destruction, myelin basic protein (MBP) depletion, and white matter degeneration, leading to demyelination and motor neuron death. The selection of MeHg+ as a potential neurotoxicant is based on our evidence that it has been connected to the development of ALS-like characteristics. It causes glutamate-mediated excitotoxicity, calcium-dependent neurotoxicity, and an ALS-like phenotype. Dysregulation of IGF-1/GLP-1 signalling has been associated with ALS progression. The bioactive amino acid 4-hydroxyisoleucine (HI) from Trigonella foenum graecum acts as an insulin mimic in rodents and increases insulin sensitivity. This study examined the neuroprotective effects of 4-HI on MeHg+-treated adult Wistar rats with ALS-like symptoms, emphasising brain IGF1/GLP-1 activation. Furthermore, we investigated the effect of 4-HI on MBP levels in rat brain homogenate, cerebrospinal fluid (CSF), blood plasma, and cell death indicators such as caspase-3, Bax, and Bcl-2. Rats were assessed for muscular strength, locomotor deficits, depressed behaviour, and spatial learning in the Morris water maze (MWM) to measure neurobehavioral abnormalities. Doses of 4-HI were given orally for 42 days in the MeHg+ rat model at 50 mg/kg or 100 mg/kg to ameliorate ALS-like neurological dysfunctions. Additionally, neurotransmitters and oxidative stress markers were examined in rat brain homogenates. Our findings suggest that 4-HI has neuroprotective benefits in reducing MeHg+-induced behavioural, neurochemical, and histopathological abnormalities in ALS-like rats exposed to methylmercury.
format Online
Article
Text
id pubmed-9228431
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92284312022-06-25 Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity Shandilya, Ambika Mehan, Sidharth Kumar, Sumit Sethi, Pranshul Narula, Acharan S. Alshammari, Abdulrahman Alharbi, Metab Alasmari, Abdullah F. Molecules Article Amyotrophic lateral sclerosis (ALS) is a severe adult motor neuron disease that causes progressive neuromuscular atrophy, muscle wasting, weakness, and depressive-like symptoms. Our previous research suggests that mercury levels are directly associated with ALS progression. MeHg+-induced ALS is characterised by oligodendrocyte destruction, myelin basic protein (MBP) depletion, and white matter degeneration, leading to demyelination and motor neuron death. The selection of MeHg+ as a potential neurotoxicant is based on our evidence that it has been connected to the development of ALS-like characteristics. It causes glutamate-mediated excitotoxicity, calcium-dependent neurotoxicity, and an ALS-like phenotype. Dysregulation of IGF-1/GLP-1 signalling has been associated with ALS progression. The bioactive amino acid 4-hydroxyisoleucine (HI) from Trigonella foenum graecum acts as an insulin mimic in rodents and increases insulin sensitivity. This study examined the neuroprotective effects of 4-HI on MeHg+-treated adult Wistar rats with ALS-like symptoms, emphasising brain IGF1/GLP-1 activation. Furthermore, we investigated the effect of 4-HI on MBP levels in rat brain homogenate, cerebrospinal fluid (CSF), blood plasma, and cell death indicators such as caspase-3, Bax, and Bcl-2. Rats were assessed for muscular strength, locomotor deficits, depressed behaviour, and spatial learning in the Morris water maze (MWM) to measure neurobehavioral abnormalities. Doses of 4-HI were given orally for 42 days in the MeHg+ rat model at 50 mg/kg or 100 mg/kg to ameliorate ALS-like neurological dysfunctions. Additionally, neurotransmitters and oxidative stress markers were examined in rat brain homogenates. Our findings suggest that 4-HI has neuroprotective benefits in reducing MeHg+-induced behavioural, neurochemical, and histopathological abnormalities in ALS-like rats exposed to methylmercury. MDPI 2022-06-16 /pmc/articles/PMC9228431/ /pubmed/35745001 http://dx.doi.org/10.3390/molecules27123878 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shandilya, Ambika
Mehan, Sidharth
Kumar, Sumit
Sethi, Pranshul
Narula, Acharan S.
Alshammari, Abdulrahman
Alharbi, Metab
Alasmari, Abdullah F.
Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
title Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
title_full Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
title_fullStr Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
title_full_unstemmed Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
title_short Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity
title_sort activation of igf-1/glp-1 signalling via 4-hydroxyisoleucine prevents motor neuron impairments in experimental als-rats exposed to methylmercury-induced neurotoxicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228431/
https://www.ncbi.nlm.nih.gov/pubmed/35745001
http://dx.doi.org/10.3390/molecules27123878
work_keys_str_mv AT shandilyaambika activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity
AT mehansidharth activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity
AT kumarsumit activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity
AT sethipranshul activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity
AT narulaacharans activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity
AT alshammariabdulrahman activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity
AT alharbimetab activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity
AT alasmariabdullahf activationofigf1glp1signallingvia4hydroxyisoleucinepreventsmotorneuronimpairmentsinexperimentalalsratsexposedtomethylmercuryinducedneurotoxicity